Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2677

Actual shortage: 256 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2412 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

24 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT CELECOXIB 200MG CAPSULE Resolved 2020-03-06 2020-09-03 107998
ACT CELECOXIB 200MG CAPSULE Resolved 2021-01-22 2021-02-12 132291
ACT CELECOXIB 100MG CAPSULE Resolved 2021-01-22 2021-02-12 132297
ACT CELECOXIB 100MG CAPSULE Resolved 2021-01-28 2021-02-12 132669
ACT CELECOXIB 200MG CAPSULE Actual shortage 2021-02-18 2021-05-06 134357
ACT CABERGOLINE 0.5MG TABLET Actual shortage 2017-05-03 2017-10-05 8767
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-17 68569
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-10 68572
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2020-02-13 68577
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-11-22 68580
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-03 2020-05-08 110797
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-23 2020-05-08 113043
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-05-01 2020-05-08 113726
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-25 2021-04-29 118960
TEVA-BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Resolved 2019-09-26 2020-01-24 94896
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2019-10-03 2020-01-24 95396
ACT BORTEZOMIB 3.5MG POWDER FOR SOLUTION Resolved 2020-01-30 2020-05-29 104930
ACT BORTEZOMIB 3.5MG POWDER FOR SOLUTION Resolved 2020-09-25 2020-10-22 125031
TEVA-ANASTROZOLE 1MG TABLET Resolved 2020-01-24 2021-01-28 104374
TEVA-AMPHETAMINE XR 3.75MG 3.75MG 3.75MG 3.75MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60068

Showing 2641 to 2660 of 2677

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 10MG TABLET Discontinued 2018-10-12 2018-10-12 63975
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81301
TEVA-LISINOPRIL/HCTZ (TYPE P) 25MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81368
TEVA-LISINOPRIL (TYPE Z) 10MG TABLET Discontinued 2019-08-15 2019-08-15 91648
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2018-10-12 2018-10-12 63978
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2018-10-19 2018-10-19 64909
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2019-04-11 2019-04-11 81298
TEVA-LISINOPRIL (TYPE P) 10MG TABLET Discontinued 2019-04-11 2019-04-11 81400
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2020-01-24 2020-01-24 104257
TEVA-LATANOPROST 50MCG SOLUTION Discontinued 2020-07-10 2020-07-10 120009
TEVA-LAMOTRIGINE 25MG TABLET Discontinued 2019-04-11 2019-04-11 81388
TEVA-LAMIVUDINE/ZIDOVUDINE 300MG 150MG TABLET Discontinued 2020-01-24 2020-01-24 104260
TEVA-IRBESARTAN 75MG TABLET Discontinued 2024-04-01 2024-04-01 224049
TEVA-HYDROMORPHONE 1MG TABLET Discontinued 2018-10-19 2018-10-19 64970
TEVA-HYDROMORPHONE 2MG TABLET Discontinued 2018-10-19 2018-10-19 64975
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2018-10-19 2018-10-19 64983
TEVA-HYDROMORPHONE 8MG TABLET Discontinued 2018-10-19 2018-10-19 64993
TEVA-HYDROMORPHONE 1MG TABLET Discontinued 2020-02-13 2020-02-13 106158
TEVA-HYDROMORPHONE 2MG TABLET Discontinued 2020-02-13 2020-02-13 106161
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2020-02-13 2020-02-13 106164

Showing 61 to 80 of 250